3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Diabetes -

Disturbed regulation of insulin production

DiabetesApr 16, 08

Disturbed regulation of insulin production: genome study casts new light on the origin of type 2 diabetes

Type 2 Diabetes is a chronic disease with rising prevalence rates throughout the world. In Germany, about 8 million people are affected. These numbers could even be an underestimation as a relatively high number of undiagnosed diabetics remains. The newly-published meta analysis 1) on the genetics of type 2 diabetes casts new light on the origin of this disease. With participation of scientists of the Helmholtz Zentrum Muenchen, the international study confirms findings that the disease is at least partly based on a misregulation of insulin producing cells.

The newly published meta analysis, in which 90 scientists from more than 40 centers were involved, evaluated data of 15 European and American studies. It was possible to identify six new genes that play a role in the development of type 2 diabetes. This brings the number of genes associated with the disease to 16.

Type 2 diabetes is characterized by perpetually raised blood sugar levels, which, untreated, can lead to damage of blood vessels, the kidneys and other important organs. Life style factors, such as overweight and lack of exercise, play an important role for disease aetiology. Nevertheless, a strong genetic component also underlies type 2 diabetes, which has been studied for some years, with the help of linkage and association studies.
The knowledge now gained allows new insights into the mechanisms responsible for the control of blood sugar levels in the blood.

The meta analysis comprises altogether studies with more than 70,000 participants. As a German contribution, data from about 2,700 participants of the KORA study were included. The involved scientists from Germany were Harald Grallert, Dr. Christa Meisinger and Dr. Thomas Illig, from the Helmholtz Zentrum Muenchen, in close collaboration with Dr. Christian Herder and Dr. Wolfgang Rathmann, from the German Diabetes Center in Duesseldorf.

The head of the KORA study (Cooperative Health Research in the Region of Augsburg) is the director of the Institute of Epidemiology in the Helmholtz Zentrum Muenchen, Prof. Dr. Dr. H.-Erich Wichmann. The coordinator of the analysis was Dr. Eleftheria Zeggini, University of Oxford, under the direction of Prof. Mark McCarthy.

Press officer:

Heinz-Jörg Haury, Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Public Affairs, Tel.: 0049-89-3187-2460, E-Mail: .(JavaScript must be enabled to view this email address) 

Neuherberg, 16 April 2008



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  New superfoods could help key protein keep bodies healthy
  Poor quality of life may affect teens’ diabetes management
  Cancer drug protects against diabetes
  Amino acid’s increase is suspected in diabetes
  New Type 2 Diabetes Drug Onglyza Approved
  Mail order pharmacy use safe for people with diabetes
  Policy considerations pose options for leaders to reduce costly disparities in diabetes
  Cedars-Sinai study sheds light on bone marrow stem cell therapy for pancreatic recovery
  Obesity-Linked Diabetes in Children Resists Treatment
  Diabetes again linked to colon cancer risk

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site